India's cheap weight-loss drugs could reshape global obesity fight
With India’s semaglutide patent expiring on 20 March, about 50 branded generics are expected to enter the market.
Coverage by Political Leaning
See how different sides of the spectrum reported this story
Key People
No people linked to this story
Locations
All Coverage
With India’s semaglutide patent expiring on 20 March, about 50 branded generics are expected to enter the market.
Similar Stories
Related coverage based on topic and tags
Weight-loss drug Wegovy to be available in pill form in UK for first time
Manufacturer Novo Nordisk says a daily tablet of the drug could be more convenient for some people than weekly injections.
June 11, 2026 at 03:00 PMUK approves Novo weight-loss pill to edge open European market - Reuters
UK approves Novo weight-loss pill to edge open European market Reuters
June 11, 2026 at 08:22 PMHow do weight-loss drugs like Mounjaro and Wegovy work?
Wegovy and Mounjaro are available to certain patients on the NHS, and can also be bought privately.
June 11, 2026 at 03:03 PMNew drug to stop 'Ozempic butt' muscle loss side effect of obesity jabs
A third of the weight loss from obesity jabs can come from muscle, say experts.
June 8, 2026 at 03:00 PMIndia sets standard pack sizes for cooking oils to help shoppers compare prices - Reuters
India sets standard pack sizes for cooking oils to help shoppers compare prices Reuters
June 6, 2026 at 12:39 PMIndia's 'blue gold' starts a new drinks industry
Agave plants grow wild in India and new distillers are using them to create a spirits industry.
June 11, 2026 at 11:01 PM